What are the arthritic manifestations in Lyme disease (Lyme borreliosis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Lyme arthritis, a late manifestation of Lyme disease, typically presents as intermittent episodes of joint swelling and pain, predominantly affecting large joints, especially the knee, with significant swelling, moderate pain, warmth, and limited range of motion in the affected joint. Patients often experience episodes that last weeks to months and can recur without treatment. The knee is involved in about 90% of cases, and episodes may be monoarticular or oligoarticular. Laboratory findings typically include elevated inflammatory markers, synovial fluid with high white blood cell counts (predominantly neutrophils), and positive serologic tests for Borrelia burgdorferi antibodies 1. Some key characteristics of Lyme arthritis include:

  • Intermittent episodes of joint swelling and pain
  • Predominantly affects large joints, especially the knee
  • Significant swelling with moderate pain, warmth, and limited range of motion
  • Episodes may last weeks to months and can recur without treatment
  • Knee is involved in about 90% of cases
  • Episodes may be monoarticular or oligoarticular
  • Laboratory findings include elevated inflammatory markers, synovial fluid with high white blood cell counts, and positive serologic tests for Borrelia burgdorferi antibodies Treatment involves antibiotics such as doxycycline (100mg twice daily for 28 days), amoxicillin (500mg three times daily for 28 days), or cefuroxime (500mg twice daily for 28 days) 1. Some patients may develop antibiotic-refractory Lyme arthritis, where joint inflammation persists despite appropriate antibiotic therapy, potentially requiring anti-inflammatory treatments. This persistent arthritis is thought to result from an autoimmune response triggered by the initial infection rather than ongoing bacterial presence. For patients with Lyme arthritis, we recommend using oral antibiotic therapy for 28 days (strong recommendation, moderate-quality evidence) 1. In patients with Lyme arthritis with no or minimal response to an initial course of oral antibiotic, we suggest a 2–4-week course of IV ceftriaxone over a second course of oral antibiotics (weak recommendation, low-quality evidence) 1.

From the Research

Clinical Presentation of Arthritis in Lyme Disease

  • Arthritis is the most common late manifestation of Borrelia burgdorferi infection in the United States, usually beginning months after the tick bite 2, 3, 4.
  • Patients with Lyme arthritis (LA) typically present with swelling and pain in one or a few large joints, especially the knee 2, 5, 3, 4.
  • The arthritis can be intermittent or persistent, and may cause severe joint pain and swelling, especially confined to one or a few joints 5.

Diagnosis and Treatment

  • Serologic testing is the mainstay of diagnosis for Lyme arthritis 2, 3, 4.
  • Synovial fluid polymerase chain reaction for B burgdorferi DNA is often positive before treatment, but is not a reliable marker of spirochetal eradication after therapy 3.
  • Antibiotic therapy is very effective in treating Lyme arthritis in the majority of cases, with responses to antibiotic treatment generally excellent 2, 5, 6.
  • A small percentage of patients may develop persistent, postinfectious synovitis after 2 to 3 months of oral and IV antibiotics, which respond to anti-inflammatory therapies 2, 5.

Persistent Arthritis

  • A small proportion of individuals may develop persistent chronic arthritis, which is likely mediated through immunologic mechanisms 5.
  • In these patients, treatment strategies should include anti-inflammatory medications and possibly immunosuppressive treatments, and arthroscopic synovectomy may be helpful in some cases 5.
  • Certain genetic and immune markers, such as HLA-DR4 specificity and OspA reactivity, may be associated with a lack of response to treatment 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Lyme Arthritis.

Infectious disease clinics of North America, 2022

Research

Diagnosis and treatment of Lyme arthritis.

Infectious disease clinics of North America, 2015

Research

Lyme Arthritis: An Update for Clinical Practice.

Pediatric emergency care, 2018

Research

Musculoskeletal manifestations of Lyme disease.

Medicine and health, Rhode Island, 2008

Research

Treatment of Lyme arthritis.

Arthritis and rheumatism, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.